Mumbai (Maharashtra) [India], February 14 (ANI/BusinessWire India): India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE: MDT) -- a global leader in healthcare technology, today announced the first clinical procedure in India with the Intellis™ spinal cord stimulation (SCS) platform, the world's smallest SCS device for the management of certain types of chronic intractable pain
\
\
